The Rap1/NCad-dependent increase in FGFR protein in vivo (Figure 3b,c) and in vitro (Figure 3—figure supplement 1a) suggests that NCad may inhibit FGFR degradation, as observed in some cancer cells (Suyama et al., 2002). The gene discussed is RAP1A; the disease is cancer.